Home > Balance Sheet > GLAND PHARMA

GLAND PHARMA
Contingent Liabilities

    Back to Balance Sheet
GLAND PHARMA is part of below Screeners ↓
Top Mid Cap Stocks with Best Fundamentals
Best 1M Momentum Mid Cap Stocks
COMMUNITY POLL
for GLAND PHARMA
Please provide your vote to see the results

GLAND PHARMA Last 5 Year Contingent Liabilities History

[Consolidated]

Mar2026Mar2025Mar2024Mar2023Mar2022
Contingent Liabilities ₹10 Cr₹21 Cr₹16 Cr₹22 Cr₹13 Cr

What is the latest Contingent Liabilities ratio of GLAND PHARMA ?

The latest Contingent Liabilities ratio of GLAND PHARMA is ₹10 Cr based on Mar2026 Consolidated results.
Year Contingent Liabilities
Mar2026₹10 Cr
Mar2025₹21 Cr
Mar2024₹16 Cr
Mar2023₹22 Cr
Mar2022₹13 Cr

How is Contingent Liabilities of GLAND PHARMA Trending?

Years Contingent Liabilities % Change
Mar2026 ₹10 Cr
-52.68
Mar2025 ₹21 Cr
37.24
Mar2024 ₹16 Cr
-29.41
Mar2023 ₹22 Cr
72.94
Mar2022 ₹13 Cr -

Compare Contingent Liabilities of peers of GLAND PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
GLAND PHARMA ₹46,228.9 Cr -2% 17.8% 43.1% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹458,249.0 Cr 1.8% -1.6% 16.5% Stock Analytics
DIVIS LABORATORIES ₹225,648.0 Cr -1.2% 17.3% 38.7% Stock Analytics
TORRENT PHARMACEUTICALS ₹184,891.0 Cr -2.3% -2% 33.6% Stock Analytics
CIPLA ₹115,927.0 Cr 0.2% 1.7% -8.8% Stock Analytics
DR REDDYS LABORATORIES ₹99,702.0 Cr 1.2% 3.6% -7% Stock Analytics


GLAND PHARMA Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
GLAND PHARMA

-2%

17.8%

43.1%

SENSEX

-0.5%

1.3%

-4%


You may also like the below Video Courses